Despite overnight strength, US equities largely lost ground today. Under pressure in particular were biotech and pharmaceutical stocks such as Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), and Bristol-Myers (NYSE:BMY). The biotech component of the NASDAQ-100 (ETF: IBB) declined by 3.03% today, leading a broader 1.18% decline in the index. The small-cap Russell 2000 (INDEXRUSSELL:RUT) underperformed today, losing 1.30% for the session. Even though many investors have turned bearish on the utilities sector due to the threat of higher interest rates, it outperformed today along with telecom-sector stocks.
A preliminary national gauge of manufacturing growth in the US showed a surprising decline to 55.5 from 57.1 last month, significantly below the 56.5 figure that had been expected for that index.
Tomorrow's Financial Outlook
Tomorrow morning's economic data reports will be centered around housing data. Early in the morning, the January S&P/Case Shiller 20-city home price index will be released with economists expecting a 13.34% gain from a year ago, little changed from the annual growth rate in the month prior. Also scheduled to be released are February new home sales and the Conference Board's index of March consumer confidence. New home sales, which make up about 10% of the total housing market, are expected to decline to an annual rate of 445,000 from 468,000 in January.
The overseas calendar remains light with only the German IFO survey of professional investors' feelings on the current economic situation and expectations, and the UK's February consumer price index due for release.
Walgreens (NYSE:WAG), PVH Corp (NYSE:PVH), and Carnival (NYSE:CCL) are scheduled to report earnings tomorrow.
Follow the markets all day every day with a FREE 14 day trial to Buzz & Banter. Over 30 professional traders share their ideas in real-time. Learn more.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.